A detailed history of Braidwell LP transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Braidwell LP holds 801,584 shares of LXRX stock, worth $689,362. This represents 0.04% of its overall portfolio holdings.

Number of Shares
801,584
Previous 8,294,950 90.34%
Holding current value
$689,362
Previous $13.9 Billion 90.97%
% of portfolio
0.04%
Previous 0.44%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.51 - $2.39 $11.3 Million - $17.9 Million
-7,493,366 Reduced 90.34%
801,584 $1.26 Billion
Q2 2024

Aug 14, 2024

BUY
$1.54 - $2.28 $12.8 Million - $18.9 Million
8,294,950 New
8,294,950 $13.9 Billion

Others Institutions Holding LXRX

About LEXICON PHARMACEUTICALS, INC.


  • Ticker LXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,726,000
  • Market Cap $162M
  • Description
  • Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...
More about LXRX
Track This Portfolio

Track Braidwell LP Portfolio

Follow Braidwell LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Braidwell LP, based on Form 13F filings with the SEC.

News

Stay updated on Braidwell LP with notifications on news.